logo_new@0,75x
  • Glycotest
  • About us
    • Management Team and Board
    • Scientific and Medical Advisors
    • Glycotest Investor Presentation
    • Investors
  • Technology
    • Clinical Data
    • Intellectual Property
  • News
  • Contact us
glycotest_logo
logo_new@0,75x
  • Glycotest
  • About us
    • Management Team and Board
    • Scientific and Medical Advisors
    • Glycotest Investor Presentation
    • Investors
  • Technology
    • Clinical Data
    • Intellectual Property
  • News
  • Contact us

Japanese Patent Further Extends Coverage for Glycotest’s Serious Liver Disease Diagnostic Technology in Asia.

July 31, 2019
-
News
-
No comments
-
Posted by glycotest
← PREVIOUS POST
Glycotest was chosen as one of 50 companies to be in the MedTech Showcase in September 2019
NEXT POST →
Glycotest’s Coverage of Key Biomarker Fucosylated Kininogen Extended by European Patent.

Leave a Comment

Your feedback is valuable for us. Your email will not be published.
Cancel Reply

Please wait...
Submit Comment

Related News

Other posts that you should not miss.

Six new patents protecting Glycotest’s HCC Panel test have been issued or allowed in the United States, Europe, China, Taiwan, Japan, and Mexico.

March 1, 2023
-
News
Read More →
Posted by glycotest
1 MIN READ

Glycotest’s Patent Portfolio Covering Detection of Serious Liver Disease Expanded by Grant of European Patent.

January 13, 2021
-
News
Read More →
Posted by glycotest
1 MIN READ

More than 50 Glycotest Fucosylated Biomarkers Protected through Grant of New US Patent.

November 3, 2020
-
News
Read More →
Posted by glycotest
1 MIN READ

GET IN TOUCH

Give Us A Call

+1 484-431-3483

Send Us A Message

info@glycotest.com

Copyright© All Rights Reserved
Website Designed & Developed by Jason and Company
Japanese Patent Further Extends Coverage for Glycotest’s Serious Liver Disease Diagnostic Technology in Asia. | Glycotest Diagnostics